Researchers found evidence correlating toxic air pollutants to increased respiratory and cardiovascular death rates.
Exposure to air pollution is associated with increased respiratory and cardiovascular mortality, according to a study published this week in The New England Journal of Medicine.
The study consisted of data showcasing differing levels of particulate matter (PM) in relation to daily all-cause, cardiovascular, and respiratory mortality rates in 652 cities across 24 countries and regions. PM is an air pollutant that has served as a public health concern due to its toxicity and widespread exposure to humans. Researchers categorized PM in the study by its aerodynamic diameter, in which PM10, deemed inhalable, had a diameter of 10 μm or less and PM2.5, deemed fine, had a diameter of 2.5 μm or less.
Global estimates were derived from each city’s concentration-response curve through 2 generalized additive models with random-effects meta-analysis to test the association between mortality and air pollution. Researchers tested the impact of an increase of 10 μg per cubic meter in the 2-day moving average of PM10 and PM2.5 concentration to compare averages over the current and previous day in association to mortality rates.
Data revealed significant associations of PM10 concentration to increases in daily all-cause mortality (0.44%; 95% CI, 0.39 to 0.50), daily cardiovascular mortality (0.36%; 95% CI, 0.30 to 0.43), and daily respiratory mortality (0.47%; 95% CI, 0.35 to 0.58). PM2.5 concentration similarly exhibited significant associations to daily mortality for all causes (0.68%; 95% CI, 0.59 to 0.77), cardiovascular (0.55%; 95% CI, 0.45 to 0.66), and respiratory (0.74%; 95% CI, 0.53 to 0.95).
Contributing author Yuming Guo, PhD, associate professor at Monash University School of Public Health and Preventative Medicine, stressed in a statement that even low levels of air pollution can increase mortality risk as there is no threshold for associations between PM and death. “Though concentrations of air pollution in Australia are lower than in other countries, the study found that Australians are more sensitive to particulate matter air pollution and cannot effectively resist its adverse impact,” said Guo.
Prior multi-city and multi-country studies have shown comparable results suggesting levels of PM slightly below the current air quality guidelines and standards remain hazardous to public health. As the largest international study to investigate the short-term impact of air pollution on death over a 30-year period, the data invokes a significant association between toxic air pollutants and death rates.
While heightened PM concentrations in areas normally affected by air pollution may raise concern, previously unaffected areas must be monitored due to physiological functions, such as tolerance, which dictates an air pollutant’s impact on mortality risk. In the study, associations between mortality and air pollution were found highest in lower annual mean PM concentrations and higher annual mean temperatures.
A total of 59.6 million deaths from all causes, 20.1 million deaths from cardiovascular disease, and 5.6 million deaths from respiratory disease were accounted for in the study. The strong correlation coefficient of 0.78 between inhalable PM10 and fine PM2.5 shows a likewise risk for humans as both these air pollutants comparably correlate to gaseous pollutants like nitrogen dioxide, ozone, sulfur dioxide, and carbon monoxide.
“The smaller the airborne particles, the more easily they can penetrate deep into the lungs and absorb more toxic components causing death,” said Guo.
Reference
Liu C, Chen R, Sera F, et al. Ambient Particulate Air Pollution and Daily Mortality in 652 Cities. [published online August 22, 2019]. The New England Journal of Medicine. doi: 10.1056/NEJMoa1817364.
Survey Results Reveal Potential Factors Slowing the Decline in Cardiovascular Mortality Rate
April 23rd 2024Research indicated that worsened glycemic, blood pressure, and obesity control, as well as increased alcohol consumption, leveled lipid control, and persistent socioeconomic disparities may have contributed to the decelerated cardiovascular mortality decline in recent years.
Read More
For National Women’s Health Week, One Company Emphasizes Cardiovascular Risk Management
May 10th 2022On this episode of Managed Care Cast, we speak with Joanne Armstrong, MD, MPH, vice president and chief medical officer for Women’s Health and Genomics at CVS Health, on the distinct pathophysiology of cardiovascular disease in women and how her own health experiences have influenced her perspective on cardiovascular disease management.
Listen
Increasing Lp(a) Awareness for Better Cardiovascular Health: Dr Mary McGowan
March 24th 2024For Lp(a) Awareness Day, Mary McGowan, MD, FNLA, chief medical officer of the Family Heart Foundation, highlights how most people with elevated Lp(a) are completely unaware that they have this increased risk and calls for increased testing.
Read More
Preventing Respiratory Illness and Death Through Tighter Air Quality Standards
June 1st 2021On this episode of Managed Care Cast, a research scholar at the Marron Institute of Urban Management at New York University discusses the latest findings in the Health of the Air report, which was presented at the recent American Thoracic Society 2021 International Conference.
Listen
6 Blood Biomarkers Identified to Predict CVD Risk in Patients With Rheumatoid Arthritis
March 15th 2024Baseline levels of serum amyloid A, C‐reactive protein, soluble tumor necrosis factor receptor 1, adiponectin, YKL‐40, and osteoprotegerin could be used to predict a rise in arterial inflammation.
Read More